Keros Therapeutics, Inc.KROSNASDAQ
Loading
Net Margin Over TimeExpanding
Percentile Rank100
Studio
Year-over-Year Change

Net income as a percentage of revenue

Latest
35.65%
↑ 100% vs avg
Percentile
P100
Near historical high
Streak
2 yr
Consecutive growthExpanding
Average
-15284.31%
Historical baseline
PeriodValueYoY Change
202535.65%+100.7%
2024-5277.55%+94.8%
2023-101319.21%-
20220.00%+100.0%
2021-292.26%-136.8%
2019-123.44%-824.6%
2018-13.35%-